Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SRRK
SRRK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SRRK News
Scholar Rock to Present at Goldman Sachs Healthcare Conference
5d ago
Newsfilter
Pharmaceutical Giants' Acquisition Targets Analysis
May 18 2026
Yahoo Finance
Scholar Rock Grants Equity Awards to New Employees
May 15 2026
Newsfilter
Scholar Rock Reports Q1 2026 Earnings with Positive FDA Progress
May 07 2026
seekingalpha
Key Wall Street Rating Changes Overview
May 06 2026
CNBC
Latest Wall Street Ratings Overview
Apr 21 2026
CNBC
US Stocks Surge on Hopes for End to Iran War
Mar 31 2026
NASDAQ.COM
Scholar Rock Resubmits Biologics License Application for SMA Treatment
Mar 31 2026
stocktwits
US Stocks Surge as Market Sentiment Improves
Mar 31 2026
NASDAQ.COM
US Stocks Surge as Market Sentiment Improves
Mar 31 2026
NASDAQ.COM
Scholar Rock Resubmits Drug Application for Apitegromab, Shares Rise
Mar 31 2026
seekingalpha
Scholar Rock Resubmits Apitegromab BLA to FDA
Mar 31 2026
Newsfilter
Scholar Rock Q4 2025 Earnings Call Insights
Mar 03 2026
seekingalpha
Scholar Rock Revises Q4 and Full Year 2025 Financial Results
Mar 03 2026
Businesswire
Scholar Rock Q4 Earnings Beat Expectations Despite No Revenue
Mar 03 2026
seekingalpha
Scholar Rock to Announce Q4 Earnings on March 2
Mar 02 2026
seekingalpha
Show More News
